Notice of Results and Investor presentation

Tristel plc

("Tristel" or the "Company")

 

Confirmation of interim results

Investor presentation

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, confirms that its interim results for the six months ended 31 December 2022 will be announced on Monday 20 February 2023.

 

Analyst briefing

A briefing open to analysts will take place in London on Monday 20 February 2023 at 9.30am. To register and for more details please contact Walbrook PR on   tristel@walbrookpr.com  

 

Investor presentation

Paul Swinney, CEO, and Liz Dixon, CFO, will provide a live hybrid presentation relating to the Company's interim results on  Monday 20 February 2023  at 4:30pm, which is open to all existing and potential shareholders.

 

For those attending in-person, the Company welcome them to 85 Gresham Street, London, EC2V 7NQ from 4.15pm for a 4.30pm start and will be followed by refreshments.

 

For those that are unable to attend, a live webcast of the investor briefing will be broadcast.

 

If you would like to register to attend in-person, or require the link for the live webcast, please contact Walbrook PR on 020 7933 8787 or email  tristel@walbrookpr.com , ensuring you detail in your email if you will attend in-person or online.

 

The results presentation will be made available on the Company's website on the day of results -  www.tristelgroup.com  

 

For further information please contact:  

 

Tristel plc	Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Chief Financial Officer
Walbrook PR Ltd	Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Applegarth	Mob: 07584 391 303
finnCap	Tel: 020 7220 0500
Geoff Nash/ Charles Beeson (Corporate Finance)
A lice Lane (ECM)